Dr Reddy\'s Lab

Interact & exchange stock tips & market info »

Expert Chartist

Platinum Member

6458 Followers

Expert Chartist

Platinum Member

6458 Followers

MMB Messenger

Platinum Member

112819 Followers

Related News »
The ANDAs for clopidogrel tablets USP, 75 mg & 300 mg are approved by the United States Food & Drug Administration (USFDA), Dr Reddy's Lab said in a statement here. The Indian pharma firm was among the first applicants to submit a substantially ...
May 17, 2012 at 23:58 | Source: in.com
- Buy rating is maintained on Dr. Reddy's Lab with a target price of Rs.1803 over one year. - Strong performance in 4QFY12 but PAT missed expectations because of a one- time adjustment. - Stock adjustment led the miss in generic Zyprexa sales to ...
May 25, 2012 at 15:13 | Source: equitybulls.com
Dr Reddy’s has also secured a 180-day marketing right for ... Plavix generic Mylan Pharmaceuticals Inc and Teva to share marketing exclusivity with Dr Reddy’s Lab Sun Pharma, Torrent Pharma and Aurobindo Pharma to sell the drug in 75 mg; Dr Reddy's ...
May 18, 2012 at 19:25 | Source: Business Standard
Dr. Reddy's Lab and Wipro BPO. Several first time recruiters also took part in the process. They included Sears IT, Medtronic, Keane Consulting, CGN Consulting, Fi-Tek, Microsoft, Accenture BPO and Wipro BPO. The highest number of offers (10 ...
May 21, 2012 at 09:42 | Source: Webindia 123
Dr Reddy’s is flat at Rs 1658 per share ... Chambal Fertilisers gained 3 percent after net profit rose 38 percent to Rs 93 crore. Divi’s lab jumped 4 percent to Rs 858 per share after net profit rose 24 percent to Rs 217 crore.
May 14, 2012 at 06:30 | Source: firstpost.com
Divi's Lab Q4 profit up 24% at Rs 217 cr 12-MAY-12 Drug firm ... it said in a filing to the BSE. Dr Reddy's Laboratories Q4 net up 2% at Rs 343 cr 11-MAY-12 Hyderabad-based pharmaceutical major, Dr Reddy’s Laboratories Limited, has witnessed a marginal ...
May 2, 2012 at 05:11 | Source: Business Standard